| NCT Number | NCT07513311 |
| Lead Sponsor | Massachusetts General Hospital
Collaborators: National Cancer Institute (NCI) |
| Conditions | Triple Negative Breast Cancer (TNBC) |
| Enrollment | 75 participants |
| Start Date | 2026-06 |
| Primary Completion | 2028-07-31 (estimated) |
| Study Completion | 2028-07-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-15 |